Atheromatous Plaque: Causes, Risks, and Treatment

Atheromatous plaque is the fatty, inflammatory buildup inside artery walls that drives most heart attacks and strokes. It forms when cholesterol-carrying particles slip beneath the thin inner lining of an artery and trigger a chain of immune reactions that, over years or decades, create a thickened, sometimes fragile lesion. The process is far more complex than “clogged pipes,” though, and the science of what makes one plaque harmless and another deadly has shifted considerably in recent years.

How Plaques Begin

The innermost layer of every artery is lined with a single sheet of endothelial cells. When that lining is healthy, it keeps blood flowing smoothly, regulates which molecules pass into the artery wall, and resists the attachment of immune cells. When it is not healthy, all of those functions degrade at once. Endothelial dysfunction is now recognized as one of the earliest contributors to atherosclerotic cardiovascular disease, setting off changes in blood clotting, vessel tone, and inflammatory signaling within the artery wall.¹

What damages the endothelium in the first place? The usual suspects are high blood pressure, smoking, high blood sugar, and obesity, but they share a common biochemical thread: they all ramp up oxidative stress inside endothelial cells, tipping the balance between protective molecules and harmful reactive oxygen species. That oxidative imbalance makes the endothelium leakier, allowing low-density lipoprotein (LDL) particles to seep into the artery wall and lodge there.² Once LDL accumulates in the tissue beneath the endothelium, the immune system treats it as an intruder, and the inflammatory cascade that will eventually build a plaque gets underway.

Geography matters, too. Plaques do not appear randomly along your arteries. They cluster at bends and branch points where blood flow is slow, turbulent, or oscillating in direction rather than streaming steadily forward. Classic research on the carotid artery bifurcation showed a strong correlation between locations of low and oscillating wall shear stress and the thickest intimal plaques.³ The endothelium at those spots is perpetually stressed, which is why the same arterial neighborhoods get hit over and over in different people.

From Fatty Streak to Dangerous Lesion

Once LDL particles are trapped in the artery wall, they become chemically modified, mostly by oxidation. The body dispatches monocytes, a type of white blood cell, which squeeze through the endothelium and transform into macrophages. These macrophages gorge on the modified LDL and swell into what pathologists call foam cells. Clusters of foam cells form the earliest visible sign of atherosclerosis, the fatty streak, which can appear as early as adolescence.⁴

A fatty streak by itself is not dangerous. It becomes a problem when foam cells die faster than the body can clean them up. In healthy tissue, dead cells are efficiently cleared by neighboring macrophages through a housekeeping process called efferocytosis. In advanced plaques, that cleanup machinery fails. Dead and dying macrophages accumulate, their contents spilling out to form a soft, lipid-rich necrotic core at the center of the plaque.⁵ Macrophage death is recognized as a critical step in necrotic core formation, and the size of that core is one of the best indicators of how unstable a plaque has become.⁶

Meanwhile, smooth muscle cells from the deeper layers of the artery wall migrate inward and begin producing collagen and other structural fibers. This creates a fibrous cap that sits over the necrotic core like a lid. If the cap is thick and intact, the plaque can remain stable for years, narrowing the artery but rarely causing an acute event. If the cap thins out, the plaque enters dangerous territory.⁷

Why Some Plaques Rupture and Others Do Not

Most heart attacks are not caused by the biggest, most flow-limiting plaques. They are caused by plaques that crack open. When the fibrous cap ruptures, the necrotic core is suddenly exposed to flowing blood. Blood clotting factors latch on almost instantly, and the resulting thrombus can block the artery within minutes. Understanding what makes a plaque vulnerable to rupture is one of the central questions in cardiovascular research.

Several features mark a plaque as high risk: a large necrotic core, a thin fibrous cap, heavy infiltration by inflammatory macrophages, and the growth of tiny new blood vessels inside the plaque itself. These new vessels, called intraplaque neovascularization, sprout from the small supply vessels in the outer artery wall in response to oxygen deprivation within the thickening plaque. The problem is that these new capillaries are structurally immature, leaky, and fragile.⁸ When they rupture, blood leaks directly into the plaque, an event known as intraplaque hemorrhage. This dumps red blood cells and their iron-rich contents into the lesion, further fueling inflammation and rapid plaque growth.⁹

Plaque rupture is not the only mechanism behind acute coronary events. Plaque erosion, where the endothelial surface over a plaque is stripped away without the cap cracking, is another important cause. Eroded plaques look quite different from ruptured ones and may call for different treatment strategies, a distinction that imaging advances are only now beginning to help clinicians make in real time.¹⁰

The Calcification Paradox

If you have ever been told that calcium in your arteries is bad news, the full picture is more nuanced. Calcification inside a plaque comes in two very different forms, and they have opposite effects on stability. Tiny microcalcifications embedded within the fibrous cap act like stress concentrators, the way a small crack in a windshield focuses force and makes the whole thing more likely to shatter. Biomechanical modeling shows these specks of calcium can generate enough local stress to trigger cap rupture.¹¹

Large, dense macrocalcifications, on the other hand, appear to stiffen and stabilize the plaque. Research on carotid plaques found that microcalcifications were significantly more common in unstable, heavily inflamed plaques, while macrocalcifications were predominantly found in stable ones and were associated with a less inflammatory immune profile.¹² So a high coronary calcium score on a CT scan does not necessarily mean your plaques are about to rupture. It does mean atherosclerosis is present, and the type and distribution of calcium matter more than the raw amount.

Risk Factors You May Not Have Heard Of

Everyone knows the traditional risk factors: high LDL cholesterol, smoking, high blood pressure, diabetes, and family history. But cardiovascular research has identified several additional drivers that help explain why some people develop aggressive plaque disease even when their standard numbers look reasonable.

Remnant cholesterol: After LDL and HDL are accounted for, there is a pool of cholesterol carried by triglyceride-rich particles. Elevated levels of this remnant cholesterol have been linked to carotid plaque formation in older adults with high blood pressure, independent of whether their LDL was well controlled.¹³
Lipoprotein(a): Often abbreviated Lp(a), this genetically determined particle promotes endothelial dysfunction, vascular inflammation, and lipid buildup in the artery wall.¹⁴ Your Lp(a) level is largely set by your genes, and standard cholesterol-lowering drugs do not reduce it much, which is why targeted therapies are in active development.
Residual inflammation: Even patients on statin therapy whose LDL is at target can carry substantial cardiovascular risk if systemic inflammation persists. UK Biobank data shows that when remnant cholesterol, Lp(a), and the inflammatory marker hsCRP are all elevated, the risk of heart attack climbs meaningfully compared to people with low levels of all three.¹⁵ Diabetes amplifies this problem by generating metabolic byproducts that intensify C-reactive protein’s damaging effects on artery walls.¹⁶
Clonal hematopoiesis (CHIP): As we age, some blood-forming stem cells acquire mutations and produce expanding clones of immune cells. Carriers of these mutations had roughly double the risk of coronary heart disease in prospective studies, and the risk was even higher in younger heart attack patients, where carriers had about four times the risk of noncarriers.¹⁷ Elevated inflammatory markers and Lp(a) appear to track with the presence of these mutations, hinting at a shared inflammatory pathway linking them to plaque progression.¹⁸

The Gut Connection

Your intestinal bacteria may also play a role. When gut microbes digest certain nutrients, particularly those abundant in red meat, eggs, and full-fat dairy, they produce a compound called trimethylamine, which the liver converts into trimethylamine N-oxide, or TMAO. Elevated TMAO in the blood has been associated with endothelial dysfunction, increased platelet activation, and a higher risk of cardiovascular events.¹⁹ More broadly, gut metabolites including TMAO, bacterial cell-wall fragments, and short-chain fatty acids have all been connected to the development or suppression of atherosclerosis, earning the gut microbiome the status of a genuine cardiovascular risk factor in its own right.²⁰ The practical takeaway is still taking shape, but it adds another reason why dietary patterns matter beyond their effects on cholesterol numbers.

How Plaques Are Detected

You can walk around with significant atheromatous plaque and have no symptoms at all. A plaque has to narrow an artery by roughly 70 percent before it restricts blood flow enough to cause chest pain during exertion. And as discussed, the plaques that cause heart attacks are often not the ones causing the most narrowing. This mismatch is why non-invasive and invasive imaging tools have become so important.

For screening, coronary artery calcium scoring uses a low-dose CT scan to quantify calcified plaque. It is widely available and reasonably inexpensive, though it tells you only about the calcified component, not the soft, lipid-rich parts. CT angiography goes further, providing a three-dimensional view of both the artery lumen and the plaque composition. During cardiac catheterization, two catheter-based imaging methods give the most detailed look at plaque structure. Intravascular ultrasound (IVUS) images the full thickness of the artery wall and is good at measuring overall plaque burden. Optical coherence tomography (OCT) uses near-infrared light to produce extremely high-resolution images of the fibrous cap. When researchers compared the two methods, cap thickness measurements from OCT and IVUS differed by less than 2 percent on average, but individual point-by-point comparisons showed errors averaging around 36 percent, highlighting that these tools still have meaningful limitations.²¹

Machine-learning algorithms are being developed to interpret these images automatically. A recent study comparing automated plaque characterization against tissue samples found that a combined near-infrared spectroscopy and IVUS system achieved about 83 percent overall accuracy in identifying plaque types, while OCT-based machine learning reached about 72 percent.²² Promising, but not yet at a level where a computer can reliably replace a cardiologist’s judgment on which plaques need intervention.

Medical Treatment

The backbone of plaque management is aggressive lipid lowering. Statins remain the first-line therapy, and high-intensity statins have been identified in meta-analyses as the most effective single class of drug for actual plaque regression, meaning the plaque physically shrinks on imaging.²³ But statins alone are often not enough. In patients who have already had a heart attack, adding a second lipid-lowering agent to a statin produced roughly double the plaque regression. A meta-analysis of randomized trials found that statin monotherapy shrank plaque volume by about 1 percent, while adding either ezetimibe or a PCSK9 inhibitor to a statin achieved about 2 percent regression, with no significant difference between the two add-on strategies.²⁴

Lowering cholesterol addresses one arm of the disease. The other arm is inflammation, and this is where treatment has evolved most in recent years. Low-dose colchicine, a long-established anti-inflammatory drug, has been shown to reduce major cardiovascular events by about 31 percent in patients with stable atherosclerosis and by about 23 percent in those recovering from a recent heart attack, on top of standard statin therapy.²⁵ Those reductions are actually larger than what most add-on lipid-lowering drugs achieve in secondary prevention trials. Pooled analyses confirm that patients with the highest inflammatory burden, as measured by hsCRP, face substantially greater cardiovascular risk even on statins, and anti-inflammatory therapy appears to help close that gap.²⁶

When Surgery Becomes Necessary

Medications work to stabilize and slowly shrink plaques, but when disease is severe, widespread, or causing acute blockages, interventional procedures come into play. Percutaneous coronary intervention, commonly known as stenting, uses a balloon catheter to open a narrowed artery and a wire-mesh stent to prop it open. It is the standard emergency treatment during a heart attack and is also used electively for highly symptomatic blockages.

Coronary artery bypass grafting (CABG) is reserved for more complex disease, particularly when multiple arteries are blocked or the left main coronary artery is involved. In patients with severely calcified or diffusely diseased vessels, surgeons sometimes need to go beyond a standard bypass. Techniques like endarterectomy, where the plaque is physically stripped from the artery wall, and patch angioplasty are used to create a graftable surface when standard attachment is not feasible.²⁷ These reconstructive approaches are more demanding, but in patients with diffuse coronary artery disease, the results can be meaningful. A study tracking heart function after coronary endarterectomy found that average pumping efficiency improved from about 47 percent before surgery to roughly 55 percent at six months, a clinically significant gain.²⁸

Lifestyle Measures That Move the Needle

No medication fully replaces healthy habits. Dietary patterns like the Mediterranean diet, the DASH diet, and plant-based eating have all been shown to improve lipid metabolism, reduce inflammation, and support endothelial function through overlapping but distinct mechanisms.²⁹ Regular aerobic exercise lowers blood pressure, improves insulin sensitivity, and independently reduces inflammatory markers. Smoking cessation is arguably the single most impactful change a smoker can make: the endothelial damage from tobacco is both a trigger for new plaque formation and a destabilizer of existing plaques.

The gut-microbiome link also gives dietary choices an additional dimension. Diets heavy in red meat and choline-rich foods feed the bacterial pathways that produce TMAO, while fiber-rich, plant-forward diets promote the production of short-chain fatty acids, which tend to have anti-inflammatory effects on the vascular system. This does not mean a single steak will cause a heart attack, but it adds mechanistic weight to the long-standing dietary guidance.

Experimental Therapies on the Horizon

One of the more striking lines of current research involves delivering anti-inflammatory instructions directly to the macrophages inside a plaque. In a preclinical study, nanoparticles loaded with messenger RNA encoding the anti-inflammatory protein IL-10 were injected intravenously into mice with advanced atherosclerosis. The nanoparticles homed in on macrophage-rich plaques and triggered those macrophages to produce IL-10 locally. The treated plaques showed reduced oxidative stress, less macrophage death, smaller necrotic cores, and thicker fibrous caps compared with untreated controls.³⁰ This is still in animal models, so it is years away from clinical use, but the concept of reprogramming a plaque’s immune environment from the inside rather than blanketing the whole body with systemic anti-inflammatory drugs represents a fundamentally different treatment philosophy. If it translates to humans, it could offer a way to stabilize the most dangerous plaques without the infection risks that come with suppressing the immune system body-wide.